5B Clinic-based Interventions: Novel, Fast, and Lean

Friday, September 23, 2016: 8:00 AM-9:15 AM
Salon B
Moderator:

8:00 AM
5B1
Improving Efficiency in the STD Clinic: An Epic Challenge
Ayesha Appa, MD1, Lindley A. Barbee, MD, MPH2, Matthew R. Golden, MD, MPH2, Robert Marks, M Ed3 and Julie Dombrowski, MD, MPH4, 1School of Medicine, University of Washington, Seattle, WA, 2HIV/STD Program and Department of Medicine, Public Health - Seattle & King County and University of Washington, Seattle, WA, 3STD Clinic at Harborview, Public Health - Seattle & King County, Seattle, WA, 4Division of Allergy and Infectious Diseases, Medicine, University of Washington, Seattle, WA
8:15 AM
5B2
Evaluation of an Express Care Triage Model for Identifying Clinically Relevant Cases in an STD Clinic
Laura C. Chambers, MPH1, Lisa E. Manhart, PhD, MPH2, David A. Katz, PhD, MPH3, Matthew R. Golden, MD, MPH3, Lindley A. Barbee, MD, MPH3 and Julia C. Dombrowski, MD, MPH3, 1Department of Epidemiology, University of Washington, Seattle, WA, 2Departments of Epidemiology and Global Health, University of Washington, Seattle, WA, 3HIV/STD Program and Department of Medicine, Public Health - Seattle & King County and University of Washington, Seattle, WA
8:30 AM
5B3
Use of a Comprehensive Internet-Based STI/HIV Testing Service in Vancouver, British Columbia and Uptake By Promotion Strategy
Mark Gilbert, MD, MHSc, FRCPC1, Travis Salway Hottes, MSc1, Devon Haag, MSc1, Mark Bondyra, BFA1, Kimberly Thomson, MA1, Natalie Holgerson, RN, BScN1, Troy Grennan, MD, FRCPC1, Shannon Kopp, BA1, Christopher Fairley, PhD2, Mel Krajden, MD, FRCPC3, Mark Tyndall, MD, FRCPC1, Jean Shoveller, PhD4 and Gina Ogilvie, MD, MSc, FCFP, DrPH5, 1Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 2Central Clinical School, Monash University, Melbourne, Australia, 3British Columbia Public Health Laboratory, Vancouver, BC, 4BC Centre for Excellence in HIV/AIDS, Vancouver, BC, 5BC Women's Hospital and Health Centre, Vancouver, BC
8:45 AM
5B4
High Prevalence of Hepatitis C Infection Identified through Targeted Screening in a Sexually Transmitted Disease Clinic in North Carolina
Arlene C. Sena, MD, MPH1, Alison Hilton, MPH2 and Christopher Hurt, MD1, 1Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Durham County Department of Public Health, Durham, NC
9:00 AM
5B5
A Phase II Trial of Single-Dose Oral ETX0914 (AZD0914) for Treatment of Uncomplicated Urogenital Gonorrhea
Stephanie N. Taylor, MD1, Jeanne Marrazzo, MD, MPH2, Byron Batteiger, MD3, Ned Hook III, MD4, Arlene C. Sena, MD, MPH5, Michael Wierzbicki, PhD6, Hannah Kwak, BS7, Shacondra Johnson, BSPH8, Kenneth Lawrence, PharmD9 and John Mueller, PhD9, 1Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA, 2Division of Infectious Diseases, University of Alabama Birmingham, Birmingham, AL, 3Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, 4Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 5Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, 6Biostatistics, EMMES Corporation, Rockville, MD, 7Biostatistics, Emmes Corporation, Rockville, MD, 8FHI 360, Durham, NC, 9Clinical Development, Entasis Therapeutics, Waltham, MA
See more of: Oral and Poster